ABT-450 combined with ritonavir, in addition to ABT-333 and ribavirin: a race for an interferon-free regimen to cure HCV infection
- PMID: 23707374
- DOI: 10.1016/j.jhep.2013.05.020
ABT-450 combined with ritonavir, in addition to ABT-333 and ribavirin: a race for an interferon-free regimen to cure HCV infection
Keywords: Chronic hepatitis C; DAA; Direct-acting antivirals; NS5A inhibitors; PegIFN; RVR; Resistance; SVR; Safety; Sustained virological response; direct-acting antivirals; eRVR; extended rapid virological response; pegylated interferon; rapid virologic response; sustained virological response.
Comment on
-
Exploratory study of oral combination antiviral therapy for hepatitis C.N Engl J Med. 2013 Jan 3;368(1):45-53. doi: 10.1056/NEJMoa1208809. N Engl J Med. 2013. PMID: 23281975 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources